Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs
- PMID: 19797757
- PMCID: PMC4451117
- DOI: 10.2105/AJPH.2008.159327
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs
Abstract
Objectives: We examined racial/ethnic disparities in HIV infection among injection drug users (IDUs) before and after implementation of large-scale syringe exchange programs in New York City.
Methods: Participants were recruited from IDUs entering the Beth Israel drug detoxification program in New York City. Participants (n = 1203) recruited from 1990 through 1994, prior to large-scale syringe exchange programs (pre-exchange), were compared with 1109 participants who began injecting in 1995 or later and were interviewed in 1995 through 2008 (post-exchange).
Results: There were large differences in HIV prevalence among pre-exchange vs post-exchange participants (African Americans, 57% vs 15%; Hispanics, 53% vs 5%; Whites, 27% vs 3%). Pre- and post-exchange relative disparities of HIV prevalence were similar for African Americans vs Whites (adjusted odds ratio [AOR] = 3.46, 95% confidence interval [CI] = 2.41, 4.96 and AOR = 4.02, 95% CI = 1.67, 9.69, respectively) and Hispanics vs Whites (AOR = 1.76, 95% CI = 1.49, 2.09 and AOR = 1.49, 95% CI = 1.02, 2.17). Racial/ethnic group differences in risk behavior did not explain differences in HIV prevalence.
Conclusions: New interventions are needed to address continuing disparities in HIV infection among IDUs, but self-reported risk behaviors by themselves may not be adequate outcome measures for evaluating interventions to reduce racial/ethnic disparities in HIV infection.
References
-
- Altice F, Mostashari F, Selwyn P, et al. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr. 1998;18(5):444–453. - PubMed
-
- Caussy D, Weiss SH, Blattner WA, et al. Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs. AIDS Res Hum Retroviruses. 1990;6(12):1459–1467. - PubMed
-
- Chaisson R, Bacchetti P, Osmond D, Brodie B, Sande M, Moss A. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989;261:561–565. - PubMed
-
- D'Aquila R, Peterson L, Williams A, William A. Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users. J Acquir Immune Defic Syndr. 1989;2:503–513. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical